Diagnostic Challenges in Invasive Mole With 18F-FDG PET/CT.


Journal

Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109

Informations de publication

Date de publication:
22 Jul 2024
Historique:
medline: 24 7 2024
pubmed: 24 7 2024
entrez: 24 7 2024
Statut: aheadofprint

Résumé

A 34-year-old woman underwent 18F-FDG PET/CT scan following a diagnosis of an invasive mole. Although CT indicated multiple lung metastases, FDG uptakes were not evident. In contrast, FDG uptakes were observed in the pelvic lesion including the left ovary, suggestive of ovarian metastasis. MRI disclosed a ring-shaped enhancement typical of a corpus luteum. This corpus luteum was supposed to be maintained by the elevated human chorionic gonadotropin excreted from the invasive mole. This case underlines the importance of careful interpretation of 18F-FDG PET/CT in the evaluation of invasive moles, highlighting potential false positive in corpus luteum.

Identifiants

pubmed: 39045720
doi: 10.1097/RLU.0000000000005378
pii: 00003072-990000000-01222
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and sources of funding: none declared.

Références

Numnum TM, Leath CA 3rd, Straughn JM Jr., et al. Occult choriocarcinoma discovered by positron emission tomography/computed tomography imaging following a successful pregnancy. Gynecol Oncol. 2005;97:713–715.
Sone T, Yoshikawa K, Fukunaga M. Pulmonary tumor embolism from choriocarcinoma: detection with F-18 FDG positron emission tomography. Clin Nucl Med. 2008;33:773–774.
Suga K, Nawata S, Kawakami Y, et al. F-18 FDG PET/CT findings of a case of complete hydatidiform mole. Clin Nucl Med. 2009;34:314–315.
Maruoka Y, Abe K, Baba S, et al. A case of pulmonary choriocarcinoma metastasis with unusual FDG-PET and CT findings: correlation with pathology. Ann Nucl Med. 2012;26:835–839.
Sironi S, Picchio M, Mangili G, et al. [18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients. Gynecol Oncol. 2003;91:226–230.
Chang TC, Yen TC, Li YT, et al. The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study. Eur J Nucl Med Mol Imaging. 2006;33:156–163.
Mapelli P, Mangili G, Picchio M, et al. Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia. Eur J Nucl Med Mol Imaging. 2013;40:505–513.
Mangili G, Bergamini A, Giorgione V, et al. [18F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective. Q J Nucl Med Mol Imaging. 2016;60:103–116.

Auteurs

Akihiko Minami (A)

From the Department of Radiology, Kyoto City Hospital.

Ryusuke Nakamoto (R)

Preemptive Medicine and Lifestyle Related Disease Research Center.

Takuto Shimamura (T)

Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yurika Kitano (Y)

Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yuji Nakamoto (Y)

Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Classifications MeSH